a florbetaben 18F-labelled radioactive diagnostic agent for the in vivo PET imaging of the human brain, to detect and measure β-amyloid neuritic plaques as a means to evaluate patients for Alzheimer's disease or other causes for cognitive decline, prepared, dispensed and delivered by manufacturing sites (“Manufacturing Sites”) arranged by or on behalf of LMI;